All In MedTech

Device Trial Radar · NCT03101007

RSA RCT: Attune RP TKA Versus LCS RP TKA

A CLINICAL RANDOMIZED CONTROLLED RSA TRIAL COMPARING THE CEMENTLESS ATTUNE ROTATING PLATFORM KNEE SYSTEM TO THE CEMENTLESS LCS ROTATING PLATFORM KNEE SYSTEM

Last checked: Nov 19, 2026Latest source record: Apr 27, 2022 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

61

Actual

Start

Jul 25, 2017

Primary completion

Jun 5, 2021

Study completion Jun 5, 2021

Sponsor

Lead sponsor
Spaarne GasthuisAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Leiden University Medical Center
First posted
Apr 4, 2017

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Single (participant)
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 21 years, up to 90 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The LCS Complete Cementless Knee by DePuy Synthes is a rotating platform knee replacement with a good clinical track record and good survival rates. The cementless ATTUNE Cruciate Sacrificing (CS) Rotating Platform Knee by DePuy Synthes has been designed to provide better range of motion and address the unstable feeling some patients experience during everyday activities, such as stair descent and bending. It is expected that the cementless ATTUNE Rotating Platform Knee will have regulatory approval early 2016. Patient inclusion will start after regular approval has been obtained. The objective of this study is to accurately assess and compare migration, clinical and radiological outcome and patient reported outcomes (PROMS) of two TKR prostheses: the Cementless ATTUNE Rotating Platform Cruciate Sacrificing Knee System and the LCS Complete Cementless Cruciate Sacrificing Knee System (rotating platform design), both by DePuy Synthes, Warsaw, Indiana, USA. In this single-blind, randomized non-inferiority trial, 32 patients with the ATTUNE Knee System and 32 patients with LCS Knee System will be included. The study population will consist of patients with symptomatic osteoarthritis of the knee scheduled for TKR surgery at the Department of Orthopaedics, Spaarne Gasthuis, Hoofddorp, The Netherlands. Annually 300 TKA procedures are performed in this department, of which about 95% is Osteo Arthritis (OA). The investigator anticipates that inclusion can be accomplished within a 1 year period and that the total study duration is 3 years. Main study parameters/endpoints are: * Migration, measured by means of RSA. * Patient Reported Outcome Measures by means of questionnaires.

Conditions

  • Osteoarthritis Arthritis
  • Joint Disease
  • Musculoskeletal Disease

Interventions

  • ATTUNE Knee Prosthesis by DePuyDevice

    Total Knee Replacement (TKR) Surgery with cementless ATTUNE rotating platform Knee Prosthesis by DePuy

  • LCS Knee Prosthesis by DePuyDevice

    Total Knee Replacement Surgery with cementless LCS rotating platform Knee Prosthesis by DePuy

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Migration, measured by means of RSATime frame: 2 Years

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • Spaarne Gasthuis

    Hoofddorp, Netherlands

  • Leiden University Medical Center

    Leiden, Netherlands

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.